Centre Hospitalier Lyon Sud
Verified
Pierre Benite, France
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This clinical trial is focused on studying Crohn's Disease, a condition that causes inflammation in the digestive tract, leading to symptoms like abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. The study is testing a treatment called Guselkumab, which is given as an injection under the skin. Guselkumab is a type of protein that may help reduce inflammation in the body. The trial also includes a comparison with a placebo, which is a substance with no active medication, to evaluate the effectiveness of Guselkumab.
The purpose of this study is to assess how well Guselkumab works and how safe it is for people with moderately to severely active Crohn's Disease. Participants in the study will receive either Guselkumab or a placebo. The study will last for several weeks, during which participants will receive regular injections and attend follow-up visits to monitor their health and the effects of the treatment.
Throughout the study, researchers will look for signs of improvement in the participants' symptoms and check for any side effects. The main goal is to see if Guselkumab can help achieve clinical remission, which means a significant reduction or disappearance of symptoms, and an endoscopic response, which is an improvement seen during an examination of the digestive tract. The study aims to provide valuable information about the potential benefits of Guselkumab for people living with Crohn's Disease.
The trial runs in 5 steps – from screening to follow-up. Each step says what happens and what the team monitors.
8 criteria
624 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Pierre Benite, France
Chojnice, Poland
Budapest, Hungary
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.